NO168422C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte benzamider - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte benzamider

Info

Publication number
NO168422C
NO168422C NO883428A NO883428A NO168422C NO 168422 C NO168422 C NO 168422C NO 883428 A NO883428 A NO 883428A NO 883428 A NO883428 A NO 883428A NO 168422 C NO168422 C NO 168422C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
substituted benzamides
analogy procedure
analogy
Prior art date
Application number
NO883428A
Other languages
English (en)
Norwegian (no)
Other versions
NO168422B (no
NO883428L (no
NO883428D0 (no
Inventor
Armando Vega Noverola
Jose Manuel Prieto Soto
Fernando Pujol Noguera
Jacinto Moragues Mauri
Robert Geoffrey Willi Spickett
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of NO883428D0 publication Critical patent/NO883428D0/no
Publication of NO883428L publication Critical patent/NO883428L/no
Publication of NO168422B publication Critical patent/NO168422B/no
Publication of NO168422C publication Critical patent/NO168422C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO883428A 1987-08-03 1988-08-02 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte benzamider NO168422C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878718345A GB8718345D0 (en) 1987-08-03 1987-08-03 N-substituted benzamides

Publications (4)

Publication Number Publication Date
NO883428D0 NO883428D0 (no) 1988-08-02
NO883428L NO883428L (no) 1989-02-06
NO168422B NO168422B (no) 1991-11-11
NO168422C true NO168422C (no) 1992-02-19

Family

ID=10621740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883428A NO168422C (no) 1987-08-03 1988-08-02 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte benzamider

Country Status (22)

Country Link
US (2) US4877780A (de)
EP (1) EP0302699A3 (de)
JP (1) JPS6450883A (de)
KR (1) KR890003760A (de)
CN (1) CN1031701A (de)
AU (1) AU629175B2 (de)
CS (1) CS272794B2 (de)
DD (1) DD282010A5 (de)
DK (1) DK429988A (de)
FI (1) FI883592A (de)
GB (1) GB8718345D0 (de)
HU (1) HU200460B (de)
IL (1) IL87080A (de)
MX (1) MX12478A (de)
NO (1) NO168422C (de)
NZ (1) NZ225657A (de)
PH (1) PH25048A (de)
PL (1) PL154302B1 (de)
PT (1) PT88175A (de)
RO (1) RO101203B (de)
SU (1) SU1739849A3 (de)
ZA (1) ZA885418B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
DE3782651T2 (de) * 1987-06-17 1993-03-25 Delagrange Lab Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
IL100432A (en) * 1990-12-27 1996-01-19 Erba Carlo Spa Dihydrobenzopuran carboxamides, their preparation and pharmaceutical preparations containing them
TW213460B (de) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
EP0554794B1 (de) * 1992-02-04 1998-07-29 Eisai Co., Ltd. Aminobenzoesäure Derivate
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
US6083991A (en) 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
AR022338A1 (es) 1999-02-04 2002-09-04 Hokuriku Pharmaceutical Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6479510B2 (en) 2000-08-18 2002-11-12 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
KR100381886B1 (ko) * 2001-03-21 2003-04-26 유니모씨엔티 주식회사 무선통신용 중계기의 씨디엠에이 신호 검출장치
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
EP1419162A1 (de) * 2001-08-24 2004-05-19 Pharmacia &amp; Upjohn Company Substituierte aryl-7-aza 2,2,1 bicycloheptane zur behandlung von krankheiten
MXPA04007936A (es) 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.
JP2005525357A (ja) * 2002-02-20 2005-08-25 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー α7ニコチン性アセチルコリン受容体活性を伴うアザ二環式化合物
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2253316B1 (de) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin-5-HT3-Rezeptorantagonisten zur Verwendung bei der Behandlung oder Prävention einer Innenohr-Pathologie mit Vestibularisdefiziten
CN102458400B (zh) 2009-05-20 2014-10-08 国立健康与医学研究所 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
US9692588B2 (en) 2015-07-07 2017-06-27 Samsung Electronics Co., Ltd. System and method for performing synchronization and interference rejection in super regenerative receiver (SRR)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068700A1 (de) * 1981-06-29 1983-01-05 Beecham Group Plc Azabicycloalkylbenzamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
EP0099194A3 (de) * 1982-07-03 1984-04-11 Beecham Group Plc Benzamide
EP0102195A3 (de) * 1982-08-03 1984-04-11 Beecham Group Plc Substituierte Azabicycloalkyl-Derivate mit dopaminantagonistischer Wirkung
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
US4870181A (en) * 1985-02-04 1989-09-26 A. H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2])octan-3-yl)aminobenzamides
EP0220011A3 (de) * 1985-10-12 1990-01-03 Beecham Group Plc Verwendung von Azabicycloalkylbenzamiden zur Behandlung von Magen-Darmbewegungskrankheiten, Migräne, Emesis, Migränekopfschmerzen, Trigeminusneuralgie und Arhythmie
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs

Also Published As

Publication number Publication date
FI883592A (fi) 1989-02-04
KR890003760A (ko) 1989-04-17
DK429988D0 (da) 1988-08-02
DK429988A (da) 1989-04-05
CN1031701A (zh) 1989-03-15
DD282010A5 (de) 1990-08-29
ZA885418B (en) 1989-04-26
PL274010A1 (en) 1989-10-16
HUT48246A (en) 1989-05-29
AU629175B2 (en) 1992-10-01
NO168422B (no) 1991-11-11
NZ225657A (en) 1991-07-26
US4937236A (en) 1990-06-26
JPS6450883A (en) 1989-02-27
CS539788A2 (en) 1990-06-13
SU1739849A3 (ru) 1992-06-07
PT88175A (pt) 1989-06-30
HU200460B (en) 1990-06-28
AU2029388A (en) 1989-02-09
US4877780A (en) 1989-10-31
EP0302699A3 (de) 1990-07-11
EP0302699A2 (de) 1989-02-08
PL154302B1 (en) 1991-07-31
FI883592A0 (fi) 1988-08-01
RO101203B (ro) 1992-01-10
IL87080A0 (en) 1988-12-30
NO883428L (no) 1989-02-06
CS272794B2 (en) 1991-02-12
GB8718345D0 (en) 1987-09-09
PH25048A (en) 1991-01-28
IL87080A (en) 1992-09-06
MX12478A (es) 1993-12-01
NO883428D0 (no) 1988-08-02

Similar Documents

Publication Publication Date Title
NO168422C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte benzamider
NO169543C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive peptidaseinhibitorer
NO171506C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater
NO172045C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer
NO168353C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2&#39;-aminofenyl)-benzamidderivater
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO169070C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterosyklisk-n-(4-piperidyl)-amider
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO881613D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk-alifatiske karboksamider.
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO168644C (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-(pyrrol-1-yl)pyridinaminer
NO170021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater